Source: PR Newswire

Press Release: PDL BioPharma : PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

INCLINE VILLAGE, Nev., Oct. 29, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its third quarter 2020 financial results for the period ended September 30, 2020, on Monday, November 9, 2020 after market close. PDL's...

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
John McLaughlin's photo - President & CEO of PDL BioPharma

President & CEO

John McLaughlin

CEO Approval Rating

40/100

Read more